Pediatric-Type Diffuse High-Grade Glioma

Pediatric-Type Diffuse High-Grade Glioma — Trials · CancerIndex

Clinical trials

Registered studies

38 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 18
Ph III recruiting: 1
Growth YoY: —
Industry share: 19%
Top sponsor: Institute of Cancer Research, United Kingdom
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05457959	Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant	withdrawn	Phase 1	0	Jonsson Comprehensive Cancer CenterOTHER	1	Feb 24, 2025	clinicaltrials

Data updated 22 days agoSource updated Feb 24, 2025source: clinicaltrials